ideasIdea
A structured pathway for patients declining proven treatment
When someone refuses recommended treatment, do not just record it. Offer a second conversation, address the beliefs behind it, keep the door open and track what happens.
Refusal of standard therapy is associated with markedly worse survival in observational studies, and many refusals reflect misinformation, fear of toxicity or distrust rather than settled values. The proposal is a standard pathway: a documented exploration of reasons, a second consultation with a different clinician or navigator, targeted information addressing the specific belief, an explicit offer to revisit at defined intervals, and registry tracking of refusals and outcomes.
Hypothesis
The pathway converts a meaningful share of initial refusals into informed acceptance or safer alternatives and improves survival among initial refusers compared with historical controls.
Rationale
Refusal is often a moment of fear rather than a fixed decision; systems currently treat it as final.
What would test it
Implement in three centres; compare rates of eventual treatment acceptance and 2-year survival among initial refusers against matched historical cohorts.
Maturity
early clinical
Who has to act
clinic
Cost to try
Small (under $1M)
Years to first evidence
2
Bottlenecks it attacks
- Misinformation and unproven therapies · Patients are sold unproven treatments and frightened away from proven ones.
- Patients lack understanding, navigation and agency · Most patients cannot understand their options, find trials, or push back, so decisions are made for them.